PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Apr-2024 Point Of Care (POC) Data Management Systems Market Opportunities, Threats, Trends, Applications, and Growth Forecast to 2033 | Marketresearch.biz Report Wired Release
15-Apr-2024 Drug Discovery Services Market Projected to Reach Valuation of USD 46.6 Billion at 11.7% CAGR from 2024-2033 | Marketresearch.biz Study Wired Release
15-Apr-2024 Galactosemia Treatment Market Expected to Double by 2032, Projected Growth at 6.8% CAGR | Marketresearch.biz Wired Release
15-Apr-2024 Particle Therapy Market: Competitive Landscape and Business Opportunities by 2033 | Marketresearch.biz Wired Release
15-Apr-2024 Breast Biopsy Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033 | Marketresearch.biz Wired Release
15-Apr-2024 Alcohol Addiction Therapeutics Market: Comprehensive Analysis, Emerging Trends, Key Growth Drivers, and Future Forecasts through 2032 | Marketresearch.biz Wired Release
13-Apr-2024 CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity CD Formulation
13-Apr-2024 CD Formulation Enables Efficacy Evaluation of Oral Thin Films: Ensuring Therapeutic Efficacy and Safety CD Formulation
12-Apr-2024 Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast Formycon AG
12-Apr-2024 Asia Green Biotechnology Corp. Announces Change of Auditor And Discontinuation of Operations in Asia AccessWire
12-Apr-2024 Beauty-Stem Biomedical Celebrates Grand Opening in Arcadia, Los Angeles AccessWire
12-Apr-2024 Community Fundraiser Hosted by CFC in Support of Infertility Awareness Week AccessWire
12-Apr-2024 Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year Formycon AG
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA
12-Apr-2024 Macomics Unveils its Lead First-in-Class Anti-Pan-LILRB Monoclonal Antibody Programme with Positive Pre-clinical Data Presented at AACR 2024 Macomics
12-Apr-2024 Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected Evolva Holding SA
12-Apr-2024 Update on Formulation of New Business Strategy AccessWire
12-Apr-2024 Pharmaceutical Cartridges Market Expected To Hit USD 3.4 Billion By 2032 Wired Release
12-Apr-2024 Sunshine Biopharma Announces Reverse Stock Split AccessWire
12-Apr-2024 ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments AccessWire